Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Untethered Microgrippers Sample Biologic Tissue

By BiotechDaily International staff writers
Posted on 13 May 2013
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
A new study describes thermally activated microgrippers that can reach narrow conduits in the body and be used to excise tissue for diagnostic analyses and biopsies.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) designed the submillimeter endoscopic microgrippers (μ-grippers) to resemble biological appendages, such as hands, with rigid phalanges and flexible joints. The residual stress powered actuators allow them to close and grasp without the need for tethers, while the rigid phalanges of the μ-grippers are composed of nickel, and hence, respond to an applied magnetic field. A thermo-sensitive polymer trigger layer on the joints keeps the μ-grippers flat at 4 °C, but softens at 37 °C, causing the μ-grippers to close.

The μ-grippers are small enough that hundreds can be deployed at a time and actuated en masse, and could therefore form the basis for a more statistically efficient means to screen large surface area organs such as the colon. To test the feasibility of biologic tissue sampling with μ-grippers, the researchers used a swine colon in ex vivo studies. They uniformly spread hundreds of μ-grippers by rotating the endoscope during the deployment. The arms of each millimeter-long μ-gripper is composed of chromium and gold actuators that naturally want to bend inwards, but are held back by the thin layer of polymer coating.

To simulate the normal human temperature, the colon was submerged in a water bath kept at 37 °C, whereupon the coating dissolved and the talons snatched up cells at close proximity; the researchers then visually verified the closure of the μ-grippers using endoscopic imaging. After closure, the vast majority of μ-grippers were retrieved using a magnetic catheter inserted through the endoscope. The researchers found that the μ-grippers identified the lesion 45% of the time; when the swarm was boosted up to 1,500 μ-grippers, the efficiency rose to 95%. The study was published in the April 2013 issue of Gastroenterology.

“Our results suggest a new paradigm in medicine whereby large numbers of small, tether-free microsurgical tools could complement individual, large, tethered biopsying devices,” concluded lead author Evin Gultepe, PhD, and colleagues of the department of chemical and biomolecular engineering. “The tissue retrieved by the μ-grippers is of sufficient quality and quantity to allow DNA and RNA extraction, as well as polymerase chain reaction (PCR) amplification in an effort to look for previously identified disease-diagnostic markers.”

Related Links:

Johns Hopkins University



Channels

Genomics/Proteomics

view channel
Image: The bone marrow of mice with normal ether lipid production (top) contains more white blood cells than are found in the bone marrow of mice with ether lipid deficiency (bottom) (Photo courtesy of Washington University School of Medicine).

Inactivating Fatty Acid Synthase Reduces Inflammation by Interfering with Neutrophil Membrane Function

The enzyme fatty acid synthase (FAS) was shown to regulate inflammation by sustaining neutrophil viability through modulation of membrane phospholipid composition. Neutrophils are the most abundant... Read more

Drug Discovery

view channel
Image: Researchers have attached two drugs—TRAIL and Dox—onto graphene strips. TRAIL is most effective when delivered to the external membrane of a cancer cell, while Dox is most effective when delivered to the nucleus, so the researchers designed the system to deliver the drugs sequentially, with each drug hitting a cancer cell where it will do the most damage (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Anticancer Drug Delivery System Utilizes Graphene Strip Transporters

The ongoing search by cancer researchers for targeted drug delivery systems has generated a novel approach that uses graphene strips to transport simultaneously the anticancer agents TRAIL (tumor necrosis... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Biotech Acquisition Designed to Accelerate the Development and Marketing of Immunosequencing Applications

Adaptive Biotechnologies Corp. (Seattle, WA, USA), a developer of next-generation sequencing (NGS) to profile T-cell and B-cell receptors, has acquired of Sequenta, Inc. (South San Francisco, CA, USA), which is expected to expedite and expand the use of innovative immunosequencing technology for researchers and clinicians... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.